ORAGENICS, INC. Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31)
ORAGENICS, INC. (OGEN) reported Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) of 8.67 million shares for the 1-month period ending 2012-07-31, per its 10-Q filed 2012-11-14.
Discontinued › Notes
us-gaap:StockIssuedDuringPeriodSharesIssuedForCash · last filed 2012-11-14
- 2012-07-31: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 8.67M shares.
- 2012-07-30: Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month 866.66K shares.
| Period end | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) 1 month |
|---|---|
| 2012-07-31 | 8.67M shares 10-Q · filed 2012-11-14 |
| 2012-07-30 | 866.66K shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |